GA
Goldstein Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $622K | Sell |
3,352
-2,124
| -39% | -$394K | 0.08% | 78 |
|
|
2025
Q1 | $1.15M | Buy |
5,476
+156
| +3% | +$32.7K | 0.17% | 49 |
|
|
2024
Q4 | $945K | Hold |
5,320
| – | – | 0.14% | 58 |
|
|
2024
Q3 | $1.05M | Buy |
5,320
+186
| +4% | +$36.7K | 0.16% | 50 |
|
|
2024
Q2 | $881K | Buy |
5,134
+120
| +2% | +$20.6K | 0.15% | 52 |
|
|
2024
Q1 | $913K | Buy |
5,014
+30
| +0.6% | +$5.46K | 0.16% | 53 |
|
|
2023
Q4 | $772K | Buy |
4,984
+138
| +3% | +$21.4K | 0.13% | 82 |
|
|
2023
Q3 | $722K | Buy |
4,846
+514
| +12% | +$76.6K | 0.15% | 55 |
|
|
2023
Q2 | $584K | Sell |
4,332
-494
| -10% | -$66.6K | 0.12% | 67 |
|
|
2023
Q1 | $769K | Sell |
4,826
-444
| -8% | -$70.8K | 0.17% | 56 |
|
|
2022
Q4 | $852K | Buy |
+5,270
| New | +$852K | 0.21% | 51 |
|